血小板淋巴细胞比率与急性心肌梗死患者行经皮冠脉介入术预后相关性研究进展  

Correlation Between Platelet Lymphocyte Ratio and Prognosis of Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention

作　　者：刘涛 周鹏[1,2] LIU Tao;ZHOU Peng(Chengdu Medical College,Chengdu 610500,Sichuan,China;Department of Cardiology,The First Affiliated Hospital of Chengdu Medical College,Chengdu 610500,Sichuan,China)

机构地区：[1]成都医学院,成都新都610500 [2]成都医学院第一附属医院心血管内科,成都新都610500

出　　处：《心血管病学进展》2018年第1期123-126,共4页Advances in Cardiovascular Diseases

基　　金：国家自然科学基金应急管理项目(81641058);北京力生心血管健康基金会领航基金项目(LHJJJ20157620)

摘　　要：急性心肌梗死是严重威胁人类生命健康的一种疾病,而经皮冠脉介入术是该疾病最迅速且效果最好的一种治疗措施,但术后仍有部分患者近期及远期预后较差。因此,找寻快速、有效的生物学指标对于急性心肌梗死患者经皮冠脉介入术预后的情况进行严重程度分级,并指导患者经皮冠脉介入术后的近期及远期的个体化诊疗尤为重要。当前国内外的部分研究者开始关注和研究血小板淋巴细胞比率作为一个新的独立预测因子与冠心病的关联,目前已逐步成为一个新的炎症标志,现着重阐述血小板淋巴细胞比率与急性心肌梗死患者行经皮冠脉介入术预后相关性的研究进展。Acute myocardial infarction(AMI)is a serious threat to human life and health of a disease,and percutaneous coronary intervention(PCI)is the most rapid and best effective treatment of this disease.There are still some patients that the near-term and long-term prognosis are poor.Therefore,the search for rapid and effective biological indicators for AMI patients with P CI prognosis of the severity of the classification,and to guide the patient after P CI in the near future and long-term individual diagnosis and treatment is particularly important.Some researchers at home and abroad have begun to pay attention to the relationship between platelet lymphocyte ratio(PLR)as a new independent predictor and coronary heart disease-related disease,which has gradually become a new inflammatory marker.Research progress on the correlation between PLR and AMI in patients with P CI is reviewed in this article.

关 键 词：急性心肌梗死 经皮冠脉介入术 血小板淋巴细胞比率 相关性 

分 类 号：R544.22[医药卫生—心血管疾病] R815[医药卫生—内科学]